NCT06509529

Brief Summary

This research will be conducted to determine the effect of motivational interviewing based on the COM-B model on women's cervical cancer health beliefs and participation in screening.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 19, 2024

Completed
27 days until next milestone

Study Start

First participant enrolled

August 15, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2025

Completed
Last Updated

July 19, 2024

Status Verified

July 1, 2024

Enrollment Period

5 months

First QC Date

July 14, 2024

Last Update Submit

July 14, 2024

Conditions

Keywords

Cervical CancerMotivational InterviewingEarly Diagnosis and ScreeningHealth BeliefsNursingCOM-B Model

Outcome Measures

Primary Outcomes (2)

  • "Cervical Cancer and Pap Smear Test Health Belief Model Scale"

    The scale was developed by Güvenç et al. (2011). Higher scores from the scale indicate increased sensitivity, caring and motivation; It indicates that benefits are perceived as high for benefit perception and obstacles are perceived as high for obstacle perception.

    0th month and 1st month.

  • Status of Cervical Cancer Screening

    This form was prepared by the researcher and will evaluate women's status of being screened for cervical cancer.

    0th month and 1st month.

Study Arms (2)

Experimental group

EXPERIMENTAL

Motivational interviews based on the COM-B Model will be given to the women in the experimental group.

Other: Motivational Interviewing Based on the COM-B Model

control group

NO INTERVENTION

They will receive routine cancer screening information provided by the institution.

Interventions

Motivational Interviewing Based on the COM-B Model will be applied to the women in the experimental group.

Experimental group

Eligibility Criteria

Age30 Years - 65 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Registered at Altınordu Central Family Health Center,
  • A woman,
  • Between 30-65 years of age,
  • The one who is married,
  • Have not had a Pap Smear test in the last 5 years,
  • Has a smart phone
  • Has an internet connection,
  • Open to communication and collaboration,
  • Women who volunteer to participate in the study will be included in the study.

You may not qualify if:

  • Who had total hysterectomy surgery,
  • The pregnant one,
  • Those diagnosed with cervical cancer and
  • Women with a psychiatric diagnosis will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Uterine Cervical NeoplasmsDisease

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hacer GÖK UĞUR, Assoc.Prof.

    Ordu University

    STUDY DIRECTOR

Central Study Contacts

Hacer GÖK UĞUR, Assoc.Prof.

CONTACT

Züleyha Çakır, Nurse

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor.

Study Record Dates

First Submitted

July 14, 2024

First Posted

July 19, 2024

Study Start

August 15, 2024

Primary Completion

December 30, 2024

Study Completion

January 30, 2025

Last Updated

July 19, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share